A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
A study of nearly 400 pregnant women is among the first to show that socioeconomic status and household crowding increase the risk of getting COVID-19.
Hospitalized COVID-19 patients who received famotidine were more likely to survive, a new retrospective study has found, but it is premature to conclude that the drug is effective for COVID-19.
The most socially disadvantaged communities in NYC used the subway to a greater degree during the pandemic, and the strongest driver of subway use was the percentage of essential workers.
Kidney complications were more common in New York City COVID-19 patients than in COVID-19 patients from other regions, a new single-center study from Columbia researchers has found.
A researcher at Columbia is studying ways to improve resilience among front-line clinicians who are feeling the emotional and physical impact of the COVID-19 pandemic.
Accompanied by boisterous cheers, Columbia surgeon Tomoaki Kato, MD, left NewYork-Presbyterian Hospital today after two months of treatment for COVID-19.
By arranging video calls and attending rounds, members of the departments of anesthesiology, radiology, and surgery help families stay connected with hospitalized COVID-19 patients.
Delays in reimplementing social distancing could result in a stronger rebound of COVID-19 infections and deaths, according to an analysis by Mailman researchers.